Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01127061 · ClinicalTrials.gov registry record · NA
Study of Exercise Training in Hypertrophic Cardiomyopathy
A NA study of Cardiomyopathy, Hypertrophic, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
- 2
- Study locations
NCT01127061 is a NA study of Cardiomyopathy, Hypertrophic that has completed, run by University of Michigan. The registered enrollment target is 136 participants, below the 351-participant average among 6 other Cardiomyopathy, Hypertrophic trials with a reported enrollment target (61% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01127061, a NA study of Cardiomyopathy, Hypertrophic, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators propose a pilot randomized controlled trial to determine the safety and potential benefits of moderate intensity exercise in patients with hypertrophic cardiomyopathy. The investigators hypotheses are that exercise parameters derived from a baseline cardiopulmonary exercise test will target an appropriately safe level of exercise intensity that will not cause significant arrhythmias or exacerbate symptoms and that exercise training for 4 months will result in significant improvements in peak oxygen consumption (peak VO2) and quality of life, with neutral effects on the clinical characteristics.
Conditions Studied
Interventions
- BEHAVIORAL Exercise training
Study Locations (2)
California
- Stanford University - Stanford
Michigan
- University of Michigan Cardiovascular Center - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2010-04 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01127061
The ClinicalTrials.gov registry entry for NCT01127061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 351-participant average among 6 other Cardiomyopathy, Hypertrophic trials with a reported enrollment target (61% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiomyopathy, Hypertrophic appearing as the primary indexed condition, and to 1 intervention - of which Exercise training is the first listed.
NCT01127061 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Michigan.
Frequently Asked Questions
What is clinical trial NCT01127061 about?
NCT01127061 is a clinical study titled "Study of Exercise Training in Hypertrophic Cardiomyopathy". The investigators propose a pilot randomized controlled trial to determine the safety and potential benefits of moderate intensity exercise in patients with hypertrophic cardiomyopathy. The investigators hypotheses are that exercise parameters derived from a baseline cardiopulmonary exercise test wi...
What is the current status of trial NCT01127061?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2010-04. Estimated completion is 2016-11.
What conditions does trial NCT01127061 study?
This clinical trial studies the following conditions: Cardiomyopathy, Hypertrophic.
What interventions are being tested in trial NCT01127061?
The interventions under investigation include: Exercise training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01127061?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01127061 being conducted?
This trial has 2 study locations across California, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiomyopathy, Hypertrophic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
RECRUITING
-
A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
ACTIVE NOT RECRUITING · Phase 4
-
Study of Muscle Abnormalities in Patients With Specific Genetic Mutations
COMPLETED
-
The Impact of Exercise-Induced Cardiac Remodeling on Myocardial Efficiency
COMPLETED
-
Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.